Abstract
Purpose
To assess the value of having an onsite genetic counseling service integrated into an assisted reproductive technology (ART) center.
Methods
Since January 2021, we have offered genetic counseling at our ART center for couples whose medical history suggests risk of transmission of a genetic disorder. The percentage of couples referred for genetic counseling, the distribution of couples according to reasons for consultation, the mode of transmission in cases of Mendelian disorders, and the frequency of mutations for those with identified genetic disorders were determined.
Results
In an 18-month period, 150 of 1340 couples (11.2%) enrolled for ART treatment were referred to the genetic counseling unit. Two-thirds (99/150, 66.0%) were referred for a known genetic risk, a family history of a genetic disorder or chromosomal abnormality, a serious condition of unknown cause, or consanguinity. The remaining couples had a putative genetic risk (diminished ovarian reserve, high incidence of oocyte immaturity, recurrent abortion, or severe male infertility). Of the 99 with known genetic risk, 62 (62.7%), were approved for ART treatment, 23 (23.2%) were recommended prenatal or preimplantation testing, and 14 (14.1%) were referred for further testing before undergoing ART.
Conclusions
Our findings reveal great value in having an on-site genetic counseling unit for referral of ART patients. Such a unit makes the ART process smoother and safer for couples, and it lightens the burden of ART staff by removing responsibilities for which they are neither trained, nor should they have to assume.
Similar content being viewed by others
References
Law No. 94–654 of July 29, 1994 relating to the donation and use of elements and products of the human body, medically assisted procreation and prenatal diagnosis. https://www.legifrance-gouv-fr.
Nance MA. Genetic counseling and testing for Huntington’s disease: a historical review. Am J Med Genet B Neuropsychiatr Genet. 2017;174(1):75–92. https://doi.org/10.1002/ajmg.b.32453.
Perera CN, O’Sullivan S, Pachter N, Tan JJ, Cohen PA. Patient satisfaction with private genetic counselling for familial cancer in Western Australia: a prospective audit. Asian Pac J Cancer Prev. 2021;22(10):3253–9. https://doi.org/10.31557/APJCP.2021.22.10.3253.
Elliott AM. Genetic counseling and genome sequencing in pediatric rare disease. Cold Spring Harb Perspect Med. 2020;10(3):a036632. https://doi.org/10.1101/cshperspect.a036632.
Lilienthal D, Cahr M. Genetic counseling and assisted reproductive technologies. Cold Spring Harb Perspect Med. 2020;10(11):a036566. https://doi.org/10.1101/cshperspect.a036566.
Yarnall RS, Elango S, Manoharan A, Rodriguez SA, Bristow SL, Kumar N, Niknazar M, Hoffman D, Ghadir S, Vassena R, Chen SH, Hershlag A, Grifo J, Puig O. Evaluating genetic ancestry and self-reported ethnicity in the context of carrier screening. BMC Genet. 2017;18(1):99. https://doi.org/10.1186/s12863-017-0570-y.
De Rycke M, Berckmoes V. Preimplantation genetic testing for monogenic disorders. Genes (Basel). 2020;11(8):871. https://doi.org/10.3390/genes11080871.
Bunnell ME, Dobson LJ, Lanes A, Ginsburg ES. Use of preimplantation genetic testing for monogenic disorders and subsequent prenatal care and diagnostic testing. Prenat Diagn. 2022;42(8):1022–30. https://doi.org/10.1002/pd.6189.
Sciorio R, Tramontano L, Catt J. Preimplantation genetic diagnosis (PGD) and genetic testing for aneuploidy (PGT-A): status and future challenges. Gynecol Endocrinol. 2020;36(1):6–11. https://doi.org/10.1080/09513590.2019.1641194.
American Society for Reproductive Medicine Practice Committee Opinion. minimum standards for practices offering assisted reproductive technologies. Fertil Steril. 2021;115:578–82.
American College of Obstetricians and Gynecologists Committee Opinion: carrier screening for genetic conditions. Committee Opinion No. 691. Obstet Gynecol. 2017;129(3):e41–e55. https://doi.org/10.1097/AOG.0000000000001952.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing interests.
Additional information
Publisher's note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Benammar, A., Munnich, A., Poulain, M. et al. The importance of on-site genetic counseling for prospective assisted reproductive technology patients. J Assist Reprod Genet 40, 1341–1347 (2023). https://doi.org/10.1007/s10815-023-02802-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10815-023-02802-2